Skip to main content

Ovary and gynecologic.

2 Phase 1 studies recruiting right now, most recently updated first.

Ovary and gynecologic2 studies

Platinum-Resistant Ovarian CarcinomaNCT05225363Papers

Chimeric Antigen Receptor T-cells

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

City of Hope Medical CenterOpen the brief

Phase 1 — first-in-human trials, explained